Terms: = Colorectal cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
219 results:
1. Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants.
Chen S; Gu J; Wu K; Zhao X; Lu Y
Cancer Biol Med; 2024 Jun; 21(6):473-83. PubMed ID: 38940668
[TBL] [Abstract] [Full Text] [Related]
2. Influence of Biomarkers on Mortality among Patients with Hepatic Metastasis of colorectal cancer Treated with FOLFOX/CAPOX and FOLFIRI/CAPIRI, Including Anti-egfr and Anti-VEGF Therapies.
Popovici D; Stanisav C; Sima LV; Negru A; Murg SI; Carabineanu A
Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929620
[No Abstract] [Full Text] [Related]
3. Novel Lipid Nanocomplex Co-Carrying Bcl2 siRNA and Quantum Dots for EGF Receptor-Targeted Anti-cancer Theranosis.
Choi MJ; Kang SJ; Lee YK; Choi KC; Lee DH; Jeong HY; Kim MW; Kim KS; Park YS
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892434
[TBL] [Abstract] [Full Text] [Related]
4. Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population-based cancer registry study.
Znaor A; Eser S; Bendahhou K; Shelpai W; Al Lawati N; ELBasmi A; Alemayehu EM; Tazi MA; Yakut C; Piñeros M
Int J Cancer; 2024 Jul; 155(1):54-60. PubMed ID: 38456478
[TBL] [Abstract] [Full Text] [Related]
5. Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer.
Kavgaci G; Dizdar O; Yalcin S
Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
[TBL] [Abstract] [Full Text] [Related]
6. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
[TBL] [Abstract] [Full Text] [Related]
7. Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis colorectal cancer Patients.
Wanram S; Klaewkla N; Pinyosri P
Microrna; 2024; 13(1):56-62. PubMed ID: 38231064
[TBL] [Abstract] [Full Text] [Related]
8. Loss of RAS Mutations in Liquid Biopsies of Patients With Multi-Treated Metastatic colorectal cancer.
Albuquerque J; Neto da Silva D; Padrão T; Leal-Costa L; Bizarro R; Correia J; Baptista C; Machete M; Prazeres G; Margarido I; Fernandes G; Simões P; Timóteo T; Lopes F; Godinho J; Moreira-Pinto J; Rodrigues T; Faria A; Pulido C; Cirnes L; Teixeira JA; Passos Coelho JL
Oncologist; 2024 Mar; 29(3):e337-e344. PubMed ID: 38071748
[TBL] [Abstract] [Full Text] [Related]
9. RIZ2 at the crossroad of the EGF/egfr signaling in colorectal cancer.
Di Donato M; Di Zazzo E; Salvati A; Sorrentino C; Giurato G; Fiore D; Proto MC; Rienzo M; Casamassimi A; Gazzerro P; Bifulco M; Castoria G; Weisz A; Nassa G; Abbondanza C
J Transl Med; 2023 Oct; 21(1):736. PubMed ID: 37853459
[TBL] [Abstract] [Full Text] [Related]
10. Network approach in liquidomics landscape.
Santini D; Botticelli A; Galvano A; Iuliani M; Incorvaia L; Gristina V; Taffon C; Foderaro S; Paccagnella E; Simonetti S; Fazio F; Scagnoli S; Pomati G; Pantano F; Perrone G; De Falco E; Russo A; Spinelli GP
J Exp Clin Cancer Res; 2023 Aug; 42(1):193. PubMed ID: 37542343
[TBL] [Abstract] [Full Text] [Related]
11. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
Benusiglio PR; Elder F; Touat M; Perrier A; Sanson M; Colas C; Guerrini-Rousseau L; Tran DT; Trabelsi N; Carpentier C; Marie Y; Adam C; Bernier M; Cazals-Hatem D; Mokhtari K; Tran S; Mathon B; Capelle L; Dhooge M; Idbaih A; Alentorn A; Houillier C; Dehais C; Hoang-Xuan K; Cuzzubbo S; Carpentier A; Duval A; Coulet F; Bielle F
JCO Precis Oncol; 2023 May; 7():e2200525. PubMed ID: 37262394
[TBL] [Abstract] [Full Text] [Related]
12. Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients.
Xi Y; Bai Z; Gao S; Guo J; Zhang Z; Zhang H; Qu L; Xu B; Wang W; Shan G; Cui W; Bai W; Ji X
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8573-8580. PubMed ID: 37186065
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of Circulating Tumor DNA in Synchronous Metastatic colorectal cancer at diagnosis Predicts Overall Patient Survival.
Sayagués JM; Montero JC; Jiménez-Pérez A; Del Carmen S; Rodríguez M; Vidal Tocino R; Montero E; Sanz J; Abad M
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176143
[TBL] [Abstract] [Full Text] [Related]
14. A review on emerging targeted therapies for the management of metastatic colorectal cancers.
Deshmukh R; Prajapati M; Harwansh RK
Med Oncol; 2023 Apr; 40(6):159. PubMed ID: 37097307
[TBL] [Abstract] [Full Text] [Related]
15. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
[TBL] [Abstract] [Full Text] [Related]
16. [Targeting HER2 in colorectal cancer].
Spitzer E; Cervera P; André T; Cohen R
Bull Cancer; 2023 Apr; 110(4):402-411. PubMed ID: 36870811
[TBL] [Abstract] [Full Text] [Related]
17. Influence of location-dependent sex difference on PD-L1, MMR/MSI, and egfr in colorectal carcinogenesis.
Choi J; Kim N; Nam RH; Kim JW; Song CH; Na HY; Kang GH
PLoS One; 2023; 18(2):e0282017. PubMed ID: 36802389
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer.
Crucitta S; Ruglioni M; Novi C; Manganiello M; Arici R; Petrini I; Pardini E; Cucchiara F; Marmorino F; Cremolini C; Fogli S; Danesi R; Del Re M
Clin Chim Acta; 2023 Feb; 541():117239. PubMed ID: 36736684
[TBL] [Abstract] [Full Text] [Related]
19. Receipt of Targeted Therapy and Survival Outcomes in Patients With Metastatic colorectal cancer.
Koroukian SM; Booker BD; Vu L; Schumacher FR; Rose J; Cooper GS; Selfridge JE; Markt SC
JAMA Netw Open; 2023 Jan; 6(1):e2250030. PubMed ID: 36656585
[TBL] [Abstract] [Full Text] [Related]
20. CircIFNGR2 enhances proliferation and migration of CRC and induces cetuximab resistance by indirectly targeting KRAS via sponging to MiR-30b.
Zhang Q; Zheng Y; Liu J; Tang X; Wang Y; Li X; Li H; Zhou X; Tang S; Tang Y; Wang X; He H; Li T
Cell Death Dis; 2023 Jan; 14(1):24. PubMed ID: 36639711
[TBL] [Abstract] [Full Text] [Related]
[Next]
